Oncology Trials

Molecular Insight Pharmaceuticals currently has three oncology clinical trials underway:

Pheochromocytoma:

• A Study Evaluating Ultratrace Iobenguane I 131(MIBG) in Patients With Malignant Pheochromocytoma/Paraganglioma 
• Content Validation of Quality of Life and Symptom Questionnaires for Pheochromocytoma and Paraganglioma

Neuroblastoma:

• Phase 2a Study of Ultratrace™ Iobenguane I 131 in Patients With Relapsed or Refractory High-Risk Neuroblastoma 

Prostate Cancer

Currently, there are no prostate cancer clinical trials enrolling patients at this time. Please check back later. 

Melanoma

Currently, there are no melanoma clinical trials enrolling patients at this time. Please check back later.